Instruction for use: Haloper

Dosage form: tablets

Active substance: Haloperidol*

ATX

N05AD01 Haloperidol

Pharmacological group:

Neuroleptics

The nosological classification (ICD-10)

F20 Schizophrenia: Schizophrenic conditions; Exacerbation of schizophrenia; Schizophrenia; Chronic schizophrenia; Dementia praecox; Bleuler's disease; Psychotic discordant; Dementia early; The febrile form of schizophrenia; Chronic schizophrenic disorder; Psychosis of the schizophrenic type; Acute form of schizophrenia; Acute schizophrenic disorder; Cerebral Organic Insufficiency in Schizophrenia; Acute attack of schizophrenia; Schizophrenic psychosis; Acute schizophrenia; Sluggish schizophrenia; Sluggish schizophrenia with apathoabulic disorders; Acute stage of schizophrenia with excitation

F29 Inorganic psychosis, unspecified: Childhood psychoses; Psychomotor agitation in psychoses; Hallucinatory-delusional disorders; Hallucinatory-delusional syndrome; Intoxication psychosis; Manic-delusional disorders; Manic chronic psychosis; Manic psychosis; Acute psychosis; paranoid psychosis; Paranoid psychosis; Subacute psychosis; Presenile psychosis; Psychosis; Intoxicating psychosis; Psychosis is paranoid; Psychosis in children; Reactive psychosis; Chronic psychosis; Chronic hallucinatory psychosis; Chronic psychosis; Chronic psychotic disorder; Schizophrenic psychosis

F95 Teaki: Teak child; Children's teak; Nerve Teacks in Children; Nervous teack; Teak

R11 Nausea and vomiting: Postoperative vomiting; Nausea; Vomiting; Vomiting in the postoperative period; Vomiting medication; Vomiting in the background of radiation therapy; Vomiting uncontrollable; Vomiting in radiation therapy; Persistent vomiting; Indomitable vomiting; Postoperative nausea; Vomiting with chemotherapy; Vomiting of the central genesis; Vomiting with cytotoxic chemotherapy; Persistent hiccups; Repeated vomiting

R44.3 Hallucinations, unspecified: Hallucinatory conditions; Hallucinations; Acute hallucinatory state; Chronic hallucinatory conditions

Composition and release form

1 tablet contains haloperidol 0.5; 1.5; 5 and 10 mg; in a blister 10 pcs., in a cardboard pack of 3 or 5 blisters.

Pharmachologic effect

Pharmacological action - antipsychotic, neuroleptic, antiemetic.

Indication of the drug Haloper

Schizophrenia, manic psychosis, hallucinations, delirium; tics, Gilles de la Tourette's syndrome, behavioral disorders, stammering and other speech defects in children; indomitable vomiting.

Contraindications

Hypersensitivity, depression, coma, parkinsonism (and other extrapyramidal disorders), CNS depression.

Application in pregnancy and lactation

Contraindicated.

Side effects

Extrapyramidal disorders, euphoria, insomnia or drowsiness, lethargy, depression, headache, dizziness, confusion, large epileptic seizures, exacerbation of psychotic symptoms.

Interaction

Incompatible with tricyclic antidepressants, indirect anticoagulants, holinoblokatorami, hypotensive drugs; enhances the effects of drugs that depress the central nervous system.

Dosing and Administration

Inside. Adults with mild symptoms - 0,5-2 mg 2-3 times a day, with severe symptoms - 3-5 mg 2-3 times a day; upon reaching a satisfactory therapeutic effect, the dose is gradually reduced.

Children with behavioral disorders - 0.05 mg / kg per day, with Gilles de la Tourette syndrome - up to 10 mg per day.

Shelf life of the drug Haloper

3 years.

Do not use after the expiry date printed on the package.